These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3791559)

  • 1. 5-Fluorouracil-metronidazole combination therapy in metastatic colorectal cancer. Clinical, pharmacokinetic and in vitro cytotoxicity studies.
    Bardakji Z; Jolivet J; Langelier Y; Besner JG; Ayoub J
    Cancer Chemother Pharmacol; 1986; 18(2):140-4. PubMed ID: 3791559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
    Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
    Cancer; 1994 Mar; 73(6):1562-8. PubMed ID: 8156482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
    Erlichman C; Fine S; Wong A; Elhakim T
    J Clin Oncol; 1988 Mar; 6(3):469-75. PubMed ID: 3280741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.
    Kemeny N; Israel K; Niedzwiecki D; Chapman D; Botet J; Minsky B; Vinciguerra V; Rosenbluth R; Bosselli B; Cochran C
    J Clin Oncol; 1990 Feb; 8(2):313-8. PubMed ID: 2405107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
    Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
    J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma.
    Grem JL; McAtee N; Balis F; Murphy R; Venzon D; Kramer B; Goldspiel B; Begley M; Allegra CJ
    Cancer; 1993 Aug; 72(3):663-8. PubMed ID: 8334622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial.
    Loehrer PJ; Turner S; Kubilis P; Hui S; Correa J; Ansari R; Stephens D; Woodburn R; Meyer S
    J Clin Oncol; 1988 Apr; 6(4):642-8. PubMed ID: 3282033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of 5-fluorouracil and thymidine in advanced colorectal carcinoma.
    Sternberg A; Petrelli NJ; Au J; Rustum Y; Mittelman A; Creaven P
    Cancer Chemother Pharmacol; 1984; 13(3):218-22. PubMed ID: 6488442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer.
    Kolarić K; Potrebica V; Stanovnik M
    Oncology; 1986; 43(2):73-7. PubMed ID: 3513075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of a weekly 8-hour 5-fluorouracil and leucovorin infusion for patients with advanced colorectal cancer: dose adjusted according to its toxicity.
    Yang TS; Hsu KC; Wang HM; Lin YC
    Jpn J Clin Oncol; 2001 Dec; 31(12):610-5. PubMed ID: 11902493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan (CPT11) plus high-dose 5-fluorouracil (5-FU) and leucovorin (LV) as salvage therapy for metastatic colorectal cancer (MCRC) after failed oxaliplatin plus 5-FU and LV: a pilot study in Taiwan.
    Tai CJ; Liu JH; Chen WS; Lin JK; Wang WS; Yen CC; Chiou TJ; Chen PM
    Jpn J Clin Oncol; 2003 Mar; 33(3):136-40. PubMed ID: 12672791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group.
    Colucci G; Maiello E; Gebbia V; Giuliani F; Serravezza G; Lelli G; Leo S; Filippelli G; Nicolella G; Brandi M
    Cancer; 1999 Feb; 85(3):535-45. PubMed ID: 10091727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
    J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
    Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
    J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced colorectal and gastric cancer with cisplatinum and 5-fluorouracil. A pilot study.
    Zaniboni A; Zambruni A; Marpicati P; Gorni F; Simoncini E; Ragni F; Marini G
    Chemioterapia; 1986 Oct; 5(5):347-50. PubMed ID: 3791483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
    Natoli C; Scognamiglio MT; Martino MT; Irtelli L; De Tursi M; Cianchetti E; Mascitelli E; Tinari N; Iacobelli S
    Anticancer Res; 2000; 20(2B):1253-6. PubMed ID: 10810430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU.
    Shepard KV; Faintuch J; Bitran JD; Sweet DL; Robin E; Levin B
    Cancer Treat Rep; 1985 Jan; 69(1):123-4. PubMed ID: 4038471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy of cisplatin and 5-FU in advanced colorectal carcinoma.
    Dy C; Gil A; Algarra SM; Aparicio LA; Calvo F; Herranz P
    Cancer Treat Rep; 1986 Apr; 70(4):465-8. PubMed ID: 3698039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.